AbbVie Inc. (ABBV) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $18.20B | +7.7% |
| 2024 | $16.90B | -17.2% |
| 2023 | $20.41B | +17.2% |
| 2022 | $17.41B | -0.2% |
| 2021 | $17.45B | +13.4% |
| 2020 | $15.39B | +106.8% |
| 2019 | $7.44B | -3.6% |
| 2018 | $7.72B | +9.6% |
| 2017 | $7.04B | +20.7% |
| 2016 | $5.83B | — |